Prism

28 Jul · 741 sources · 100 stories · 36 origins

One story.
Every perspective.

Prism clusters worldwide coverage into single events, then reads each one through your professional lens — whatever your profession is. Switch the lens and the same news changes meaning.

Get your feedBrowse the news

Every value traces to a source · Free while we build · No account needed

Try it — flip the lens

Blockbuster obesity drug goes generic in India after landmark patent ruling

Through the Reader lens — the patent office cleared three manufacturers to make semaglutide from January, with prices projected to fall up to 80%. Two narratives are already competing — a public-health milestone versus patent erosion — and both are grouped on the story page.

Health and Policy are upcoming lenses — new roles ship as registry entries, not new products.

Your profession is a lens — and lenses are an open set.

A lens is a declaration: which fields get extracted, how your feed ranks, what the agent asks. Thirty-plus professions already map onto the backbone — a new one is a registry entry, never a new pipeline.

ReaderCyberMarkets
HealthnextPolicynextLegalSupply chain+ your role

Trader, CISO, policy analyst, doctor, founder, journalist, student — each maps to a lens with its own ranking, fields, and questions.

Both Sides

The same ruling is two different stories.

Prism groups a story's sources by stance, side by side, with every outlet's origin and affiliation labeled. You see every framing — and who is speaking.

Access to medicine wonIndia · Global South

Domestic and global-health outlets frame the ruling as a public-health milestone: a drug priced for the few, opened to millions.

The HinduDWPublic broadcaster
Innovation underminedUS · EU

Industry and financial press frame it as patent erosion that will chill R&D investment in the region — and warn of trade consequences.

WSJFiercePharma

How Prism reads the news

01

Cluster

Fifty duplicate headlines about one real event become a single canonical story with every source attached.

02

Balance

Each story's coverage-origin mix is measured. One origin only? It's flagged as a blindspot.

03

Lens

Written briefs re-read the same story for each profession. Lenses are added continuously on the same backbone.

04

Ground

Ask anything. The agent answers from the story's own sources with citations — or refuses, visibly.

So What

What happens next — spelled out.

Every story carries its consequence graph: who is affected first, and the likely second-order effects — each with a direction and a horizon, never vague.

“AI-chip export rules eased for allied markets” — 21 sources

Domestic data-center builders accelerated GPU procurement · weeks
Power utilities near new capacity grid-demand contracts reprice · months
Grey-market resellers arbitrage window closes · immediate
Non-allied markets domestic accelerator programs gain urgency · quarters

Blindspots

Some stories you only ever hear one way.

A blindspot is any story where only one side is speaking — every source from one country, or every outlet aligned with one party. Prism measures who's telling each story and flags what's missing.

⚠ One-sided coverageElections

State assembly passes contested electoral-roll revision bill

7 sources · all aligned with the ruling party — the opposition's framing hasn't been picked up. Prism pulls it in and shows both.

⚠ Single-originTrade

Deep-water port expansion approved on strategic shipping lane

4 sources · one origin country — the rest of the world's media hasn't picked this up yet.

Ask

Ask anything. Get sources — or honesty.

Prism AI agentGrounded in 9 sources

On: “India names T20 World Cup squad — three debutants, a shock omission”

Why was the vice-captain dropped?

Selectors cited workload management after the IPL season [3]; two reports add a fitness-test result from the June camp [6][8].

Will India win the cup?

Not in sources

The sources for this story don't cover that.

Ask anything about this story…

Refusal is a feature — the agent never asserts beyond a story's own sources.

Pick your lens. Keep the whole spectrum.

Tell us what you do — your feed, your fields, your questions follow. Your profile lives in this browser.

Choose your lens →